Recombinant constructs of Borrelia burgdorferi
US7179448B2 · kind B2 · utility
1Cited by
13References
6Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Aug 3, 2005 |
| Grant date | Feb 20, 2007 |
| Priority date | — |
| Expiry date | Aug 20, 2025 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY02A50/30
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Novel chimeric nucleic acids, encoding chimeric Borrelia proteins comprising OspC or an antigenic fragment thereof and OspA or an antigenic fragment thereof, are disclosed. Chimeric proteins encoded by the nucleic acid sequences are also disclosed. The chimeric proteins are useful as vaccine immunogens against Lyme borreliosis, as well as for immunodiagnostic reagents.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.